Oedematous Lower Limb Subcutaneous Drainage in Palliative Care (DSOPAL)

November 9, 2017 updated by: University Hospital, Limoges
  • Background : Edema of lower extremities is a concern ranging from 19 % to 60% of palliative cancer patients. Lymphedema decreases mobility, induces pain, impacts daily activities, esthetic and behavior. Usual treatment is based on diuretics and physiotherapy but is often unsuccessful. In case of conventional treatment failure, in palliative care, subcutaneous drainage can be discussed with the patients. The technique is simple, easy to use but remains off the record. Since 2004, 23 cases were reported with various methods. All the cases reported were undertaken with various technical approaches and efficacy criteria.
  • Purpose : Investigator hypothesize that the subcutaneous drainage of edema (SDO) is effective in case of refractory lymphedema of the lower limbs in palliative care and leads to an improvement in QOL in terms of behavioral and autonomy.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

• Abstract : In palliative care, lymphedema results from various associations of cancer, hypoalbuminemia, electrolytic disturbances or organ failure. The lymphatic circulation cannot be summarized by the Starling's equation and obstruction cannot explain everything. An interstitial hypothesis underlines the role of the lymphatic pump and edema volume can be a crucial point. The SDO, via the direct liquid removal, can restore the lymphatic pump function. This volumetric effect can explain the long time effect of the SDO and the large range of liquid amount reported in effective SDO. The superficial lymphatic system, in the superficial layer of derma, drains 80 % of lymph flow. In edema, the increased volume leads to the creation of subcutaneous interconnected lacunas. The subcutaneous site for drainage is justified.

After topic anesthesia, three subcutaneous channels are created on the ankle's medial face of the edematous limbs and liquids are absorbed by pads. An additional drainage can be done on the external face of the thigh with liquid collecting bags in bedridden patients.

The study includes clinical examination, total and segmental bioelectrical impedance measured at J0, J4 and on exit or at J7 at the latest and daily weight, umbilic abdominal perimeters and segmental circumferences and QOL evaluation before and after SDO. Bioelectrical impedance is collected from hand-foot, thigh root-foot and under patella calf - foot electrodes. Segmental circumferences are collected at thigh, calf and ankle points identified from bone relief distance.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France, 33000
        • University Hospital
      • Limoges, France, 87042
        • University Hospital
      • Nantes, France, 40031
        • University Hospital
      • Perigueux, France, 24019
        • Hospital
      • Toulouse, France, 31059
        • University Hospital
      • Toulouse, France, 31027
        • Joseph Ducuing hospital
      • Valenciennes, France, 59300
        • Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 18
  • palliative care patients
  • Karnofsky Scale < 50%
  • Uni or bilateral lower limb oedema even if associated with lumbar or pelvi-scrotal oedema or ascitis whatever etiology involved (cancer, organ failure, hypoalbuminemia…)
  • Effective Social security regimen affiliation
  • Signed informed consent

Exclusion Criteria:

  • Refusal to take part in the study
  • Local anesthesic contraindication
  • Infected skin lesions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Oedematous lower limb subcutaneous drainage
In case of lymphoedema in palliative situation, a subcutaneous drainage can be performed. It is a simple method, easy to use. After topic analgesia, three subcutaneous channels are created and an absorbent pad collects the lymphatic fluid.
After topic analgesia, three subcutaneous channels are created and an absorbent pad collects the lymphatic fluid.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Karnofsky's scale
Time Frame: 7 days
Change in autonomy evaluated by Karnofsky's scale between Day 7 and Day 0
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Karnofsky's scale
Time Frame: 4 Days
Change in autonomy evaluated by Karnofsky's scale between Day 4 and Day 0
4 Days
The 15th item of the European Organisation for Research and Treatment of Cancer quality of life questionnaires of palliative cancer care patients (EORTC QLQ C15 PAL),
Time Frame: 4 days and 7 days
Changes in quality of life evaluated by the 15th item of the EORTC QLQ C15 PAL scale between between Day 4/Day 7 and Day 0
4 days and 7 days
Modify Dermatology Life Quality Index (MDLQI)
Time Frame: 4 days and 7 days
Changes in quality of life related to lymphedema evaluated by the MDLQI between Day 4/Day 7 and Day 0
4 days and 7 days
Verbal numeric scale for pain
Time Frame: 4 days and 7 days
Changes in pain evaluated by the verbal numeric scale between Day 4/Day 7 and Day 0
4 days and 7 days
Bioelectrical impedance analysis of lower limbs, calves and thighs
Time Frame: 4 days and 7 days
Changes in bioelectrical impedance of lower limbs, calves and thighs between Day 4/Day 7 and Day 0.
4 days and 7 days
Segmental limb circumferences measurement
Time Frame: 4 days and 7 days
Variation of the physical measures in time. Changes in segmental limb circumferences between Day 4/Day 7 and Day 0
4 days and 7 days
Abdominal perimeter measurement
Time Frame: 4 days and 7 days
Variation of the physical measures in time. Changes in abdominal perimeter between Day 4/Day 7 and Day 0
4 days and 7 days
Weight measurement
Time Frame: 4 days and 7 days
Variation of the physical measures in time. Changes in weight between Day 4/Day 7 and Day 0
4 days and 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bertrand SARDIN, MD, University Hospital, Limoges

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 27, 2015

Primary Completion (Actual)

July 20, 2017

Study Completion (Actual)

July 20, 2017

Study Registration Dates

First Submitted

June 8, 2015

First Submitted That Met QC Criteria

June 12, 2015

First Posted (Estimate)

June 17, 2015

Study Record Updates

Last Update Posted (Actual)

November 14, 2017

Last Update Submitted That Met QC Criteria

November 9, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • I14010 DSOPAL

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Edema

Clinical Trials on subcutaneous drainage

Subscribe